Orikami enables personalized healthcare by maximizing data value.

Orikami
The earth from space

Orikami is on a mission to improve 100 million lives before 2030 by enabling personalized healthcare

Orikami

Orikami is a Dutch MedTech organization. We are specialized in applied data science. We develop and implement digital biomarkers to enable personalized healthcare for people with chronic diseases.

typing on a laptop

Our Mission

Our mission - to improve 100 million lives before 2030 by enabling personalized healthcare.

We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.

Check out our services

VALUE of Digital Biomarkers

What are digital biomarkers?

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.

Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths.

Check out our academic approach

Our clients and partners

News

Bert Seegers new CEO Orikami

As of October 1, 2022, Bert Seegers is the new CEO of Orikami. Bert has contributed to the growth of Orikami over the past 5 years as Chief Business Officer. Orikami will be pursuing a…

Read more

Measuring participation in MS with the Whereabouts app

Multiple Sclerosis can impact daily life and involvement in societal activities (participation). How do you decide which activities you want to participate in? The MS Center Amsterdam and Orikami have developed the smartphone application ‘Whereabouts’…

Read more
The earth from space

Interested in our personalized healthcare solutions?

  • This field is for validation purposes and should be left unchanged.